InnovAge (INNV) Projected to Post Quarterly Earnings on Tuesday

InnovAge (NASDAQ:INNV) is expected to be releasing its Q2 2026 results after the market closes on Tuesday, February 3rd. Analysts expect InnovAge to post earnings of $0.04 per share and revenue of $228.30 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Tuesday, February 3, 2026 at 5:00 PM ET.

InnovAge (NASDAQ:INNV) last issued its quarterly earnings results on Tuesday, November 4th. The company reported $0.06 EPS for the quarter, topping the consensus estimate of $0.01 by $0.05. InnovAge had a negative net margin of 1.96% and a negative return on equity of 7.02%. The firm had revenue of $236.11 million during the quarter, compared to analyst estimates of $226.64 million. On average, analysts expect InnovAge to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

InnovAge Price Performance

INNV stock opened at $6.04 on Tuesday. The company has a market cap of $819.51 million, a PE ratio of -46.46 and a beta of 0.57. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.25. InnovAge has a 12-month low of $2.60 and a 12-month high of $6.26. The stock has a 50-day moving average price of $5.45 and a two-hundred day moving average price of $4.80.

Insider Activity

In other news, COO Michael Anthony Scarbrough sold 33,000 shares of the firm’s stock in a transaction on Friday, November 14th. The stock was sold at an average price of $4.90, for a total transaction of $161,700.00. Following the completion of the sale, the chief operating officer directly owned 119,617 shares of the company’s stock, valued at $586,123.30. This trade represents a 21.62% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 1.00% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. Bank of America Corp DE increased its stake in InnovAge by 42.4% in the 4th quarter. Bank of America Corp DE now owns 19,945 shares of the company’s stock valued at $78,000 after buying an additional 5,936 shares during the period. JPMorgan Chase & Co. raised its holdings in InnovAge by 26.0% during the third quarter. JPMorgan Chase & Co. now owns 15,993 shares of the company’s stock valued at $83,000 after buying an additional 3,305 shares in the last quarter. Jane Street Group LLC grew its holdings in InnovAge by 18.9% during the first quarter. Jane Street Group LLC now owns 46,827 shares of the company’s stock valued at $140,000 after purchasing an additional 7,429 shares during the last quarter. Jacobs Levy Equity Management Inc. bought a new stake in InnovAge during the first quarter valued at about $166,000. Finally, Strs Ohio acquired a new stake in InnovAge in the 1st quarter valued at approximately $186,000. 12.26% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the company. Wall Street Zen upgraded InnovAge to a “strong-buy” rating in a report on Saturday, November 8th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of InnovAge in a report on Thursday. Two investment analysts have rated the stock with a Sell rating, According to MarketBeat, the stock has an average rating of “Sell” and an average price target of $5.00.

About InnovAge

InnovAge Holdings, Inc (NASDAQ:INNV) is a healthcare services company that specializes in caring for seniors through the Program of All-Inclusive Care for the Elderly (PACE). Designed for individuals who are eligible for both Medicare and Medicaid, the PACE model integrates medical care, social services and long-term care—delivered primarily in participants’ homes and community-based centers. InnovAge’s approach centers on interdisciplinary care teams that coordinate everything from primary and specialty medical services to nutritional counseling and recreational activities.

The company’s core offerings include comprehensive in-home assessments, physician and nursing services, physical and occupational therapy, prescription medication management, and transportation to medical appointments.